Moderator: Khushita Vasant

Khushita covers US antitrust enforcement and litigation for MLex in Washington, DC. She previously covered EU competition law in Brussels where she broke news on high-profile antitrust and merger investigations. She has covered the EU’s actions against Google, Apple, Facebook, and Amazon, to name a few. Now in the US, she closely tracks landmark antitrust lawsuits and investigations initiated by the Department of Justice and Federal Trade Commission against some large digital platforms. She’s often in federal courts across the US to report on high-profile civil and criminal antitrust litigation, and on Capitol Hill to cover developments on a set of critical antitrust bills pending in Congress. Khushita specializes in coverage of intellectual property, with notable scoops on US policy developments and EU investigations in the field of standard-essential patents. Her articles on SEPs have been nominated for the Concurrences Antitrust Writing Awards. Khushita previously wrote about monetary policy, and the bond and FX markets for The Wall Street Journal and Dow Jones Newswires in Mumbai.

How Counterfeit Drugs Threaten U.S. Health and Innovation

By Anne Pritchett According to the Department of Homeland Security, counterfeit drugs “threaten national security and public safety directly when introduced into government and critical infrastructure supply chains, and indirectly if used to generate revenue for transnational criminal organizations.” Furthermore, counterfeit drugs harm pharmaceutical innovation by eroding profitability and investor
Read More

U.S. Universities: Engines of Economic Growth

By Sujai Shivakumar, Charles Wessner, Chris Borges, and Shruti Sharma Universities are among the United States’ most enduring sources of competitive advantage and a key pillar of the nation’s innovation system. Home to more than 35 of the world’s top 100 research universities, the United States owes many of its most
Read More

Andrei Iancu – Congressional Testimony: Hearing on the Patent Eligibility Restoration Act (PERA)

On October 8th, 2025, Andrei Iancu testified before the Senate Judiciary Committee, Subcommittee on Intellectual Property during the Hearing on the Patent Eligibility Restoration Act (PERA). Iancu, Partner at Sullivan & Cromwell, former Under Secretary of Commerce for IP and Director of the U.S. Patent and Trademark Office (USPTO), and
Read More